This property is also extremely attractive where an established vaccine platform/regimen generating mixed CD4 and CD8 T cells could be rapidly adapted and deployed to serve as a component of a public health emergency response to control an emerging infectious disease outbreak. The gene discussed is CD8A; the disease is infectious disease.